血管内皮生长因子C(VEGFC)多克隆抗体(异硫氰酸荧光素标记)
FITC-Linked Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
VEGF-C; Flt4-L; VRPL; Vascular Endothelial Growth Factor-Related Protein
- 编号LAA145Ra81
- 物种Rattus norvegicus (Rat，大鼠) 相同的名称，不同的物种。
- 来源抗体标记
- Ig类型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物荧光素
- 原抗体 -
- 缓冲液成份磷酸盐缓冲液（pH7.4,含有0.02% NaN3和50%甘油）
- 性状液体
- 浓度500µg/mL
- 且适物种-
- 应用WB; IHC; ICC; IF.
如果抗体需用于流式细胞术，请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 765 ¥ 1785 ¥ 2550 ¥ 6375 ¥ 25500
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
通过ISO 9001、ISO 13485质量体系认证
特异性
该抗体是针对VEGFC的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别VEGFC。
用法
免疫印迹：0.2-2µg/mL;1:250-2500
免疫组织化学：5-20µg/mL;1:25-100
免疫细胞化学：5-20µg/mL;1:25-100
最佳稀释倍数最终由用户决定。
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
赠品
增值服务
相关产品
| 编号 | 适用物种：Rattus norvegicus (Rat，大鼠) | 应用(仅供研究使用，不用于临床诊断！) |
| RPA145Ra01 | 血管内皮生长因子C(VEGFC)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA145Ra01 | 血管内皮生长因子C(VEGFC)多克隆抗体 | WB; IHC; ICC; IP. |
| LAA145Ra81 | 血管内皮生长因子C(VEGFC)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
| LAA145Ra71 | 血管内皮生长因子C(VEGFC)多克隆抗体(生物素标记) | WB; IHC; ICC. |
| MAA145Ra22 | 血管内皮生长因子C(VEGFC)单克隆抗体 | WB |
| MAA145Ra21 | 血管内皮生长因子C(VEGFC)单克隆抗体 | WB; IHC; ICC; IP. |
| LAA145Ra72 | 血管内皮生长因子C(VEGFC)单克隆抗体(生物素标记) | WB; IHC; ICC. |
| SEA145Ra | 血管内皮生长因子C(VEGFC)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA145Ra | 血管内皮生长因子C(VEGFC)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
| PSA145Ra01 | 血管内皮生长因子C(VEGFC)抗体对 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSA145Ra01 | 血管内皮生长因子C(VEGFC)检测试剂盒DIY材料(酶联免疫吸附试验法) | 自己动手制作ELISA试剂盒的主要材料 |
参考文献
| 杂志 | 参考文献 |
| Journal of Cellular Biochemistry | Alternatively activated RAW264. 7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma [PubMed: 19241443] |
| genetics and molecular research | Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages [PubMed: 26125824] |
| Experimental and Therapeutic | Fenofibrate inhibits the expression of VEGFC and VEGFR-3 in retinal pigmental epithelial cells exposed to hypoxia [PubMed: 26622498] |
| Am J Pathol | IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages [PubMed: 26608451] |
| PLoS One. | Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells. [pubmed:27383632] |
| Oncology Letters | RNAi-mediated gene silencing of vascular endothelial growth factor C suppresses growth andinduces apoptosis in mouse breast cancer in vitro and in vivo. [pubmed:27895746] |
| Angiogenesis | Characterization of isolated liver sinusoidal endothelial cells for liver bioengineering [Pubmed:29582235] |
| Oncology Reports | Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells [Pubmed:29328465] |
| LABORATORY INVESTIGATION | Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease [Pubmed: 31019289] |
| Cutaneous and Ocular Toxicology | Isotretinoin does not alter VEGF-A and VEGF-C levels: Do retinoids behave differently in dose-dependent and/or in vivo/in vitro conditions? [Pubmed: 32722957] |
留言咨询